DE69842091D1 - Frazzled Nukleotidsequenzen, Expressions- produkte, Zusammensetzungen und Verwendungen - Google Patents

Frazzled Nukleotidsequenzen, Expressions- produkte, Zusammensetzungen und Verwendungen

Info

Publication number
DE69842091D1
DE69842091D1 DE69842091T DE69842091T DE69842091D1 DE 69842091 D1 DE69842091 D1 DE 69842091D1 DE 69842091 T DE69842091 T DE 69842091T DE 69842091 T DE69842091 T DE 69842091T DE 69842091 D1 DE69842091 D1 DE 69842091D1
Authority
DE
Germany
Prior art keywords
nucleotide sequences
compositions
expression products
frazzled
frazzled nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69842091T
Other languages
English (en)
Inventor
Hazel Sive
Benjamin Sun
Lisa A Racie
Edward R Lavallie
Janet E Paulsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Whitehead Institute for Biomedical Research
Original Assignee
Genetics Institute LLC
Whitehead Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC, Whitehead Institute for Biomedical Research filed Critical Genetics Institute LLC
Application granted granted Critical
Publication of DE69842091D1 publication Critical patent/DE69842091D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69842091T 1997-07-11 1998-04-28 Frazzled Nukleotidsequenzen, Expressions- produkte, Zusammensetzungen und Verwendungen Expired - Lifetime DE69842091D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/893,654 US6165748A (en) 1997-07-11 1997-07-11 Frazzled nucleotide sequences and expression products

Publications (1)

Publication Number Publication Date
DE69842091D1 true DE69842091D1 (de) 2011-02-17

Family

ID=25401869

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69842091T Expired - Lifetime DE69842091D1 (de) 1997-07-11 1998-04-28 Frazzled Nukleotidsequenzen, Expressions- produkte, Zusammensetzungen und Verwendungen
DE69832880T Expired - Lifetime DE69832880T2 (de) 1997-07-11 1998-04-28 Frazzled nukleotidsequenzen, expressionsprodukte, zusammensetzungen und verwendungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69832880T Expired - Lifetime DE69832880T2 (de) 1997-07-11 1998-04-28 Frazzled nukleotidsequenzen, expressionsprodukte, zusammensetzungen und verwendungen

Country Status (8)

Country Link
US (1) US6165748A (de)
EP (2) EP1591526B1 (de)
JP (2) JP2001509382A (de)
AT (2) ATE494375T1 (de)
AU (1) AU751803B2 (de)
DE (2) DE69842091D1 (de)
MX (1) MXPA00001427A (de)
WO (1) WO1999002679A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673909B1 (en) * 1998-08-25 2004-01-06 The General Hospital Corporation Oligonucleotides for dysferlin, a gene mutated in distal myopathy and limb girdle muscular dystrophy
US20030187054A1 (en) * 2000-03-10 2003-10-02 Shunsuke Nagao Preparations for chondrogenesis
US7713526B2 (en) 2001-05-01 2010-05-11 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
AU2002308557A1 (en) * 2001-05-01 2002-11-11 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
US20030044409A1 (en) * 2001-05-01 2003-03-06 Carson Dennis A. Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
EP1639097B1 (de) * 2003-06-25 2013-08-07 Ottawa Health Research Institute Methoden und zusammensetzungen um stammzellwachstum und -differenzierung zu modulieren
US7994126B2 (en) 2006-02-22 2011-08-09 Zhenglun Zhu Treatment of cellular proliferative disorders with compositions comprising Hom polypeptide (also known as Xom, VENTX2)
WO2007124448A2 (en) * 2006-04-20 2007-11-01 Rosero Spencer Z Method and apparatus for the management of diabetes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419446A (en) 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
EP0105014B1 (de) 1982-09-24 1992-05-20 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Wiederherstellung von Gewebe bei Tieren
US4588684A (en) 1983-04-26 1986-05-13 Chiron Corporation a-Factor and its processing signals
DK518384A (da) 1984-01-31 1985-07-01 Idaho Res Found Vektor til fremstilling af et gen-produkt i insektceller, fremgangsmaade til dens fremstilling samt dens anvendelse
EP0188479B1 (de) 1984-07-06 1991-09-11 Sandoz Ag Herstellung und reinigung von lymphokinen
DE3586386T2 (de) 1984-10-05 1993-01-14 Genentech Inc Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung.
US5646016A (en) 1991-02-06 1997-07-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
EP0605428B9 (de) 1991-06-24 2003-01-02 hCell Technology, Inc. In langzeitkultur gehaltene hormon-absondernde pankreatische zellen
US6133232A (en) * 1996-06-20 2000-10-17 The Regents Of The University Of California Endoderm, cardiac and neural inducing factors
AU4981797A (en) * 1996-10-11 1998-05-11 Government Of The United States Of America, The Isolation and method of using tissue growth-inducing frzb protein

Also Published As

Publication number Publication date
JP2001509382A (ja) 2001-07-24
US6165748A (en) 2000-12-26
WO1999002679A1 (en) 1999-01-21
AU751803B2 (en) 2002-08-29
AU7363198A (en) 1999-02-08
DE69832880D1 (de) 2006-01-26
EP1000143A1 (de) 2000-05-17
EP1591526A2 (de) 2005-11-02
EP1591526A3 (de) 2007-08-08
DE69832880T2 (de) 2006-06-22
MXPA00001427A (es) 2005-01-25
EP1000143B1 (de) 2005-12-21
ATE494375T1 (de) 2011-01-15
EP1591526B1 (de) 2011-01-05
ATE313627T1 (de) 2006-01-15
JP2009142287A (ja) 2009-07-02

Similar Documents

Publication Publication Date Title
IL149459A0 (en) Recombinant gelatins
DE69708120D1 (de) Laser-absorbierende, lichtbleichbare zusammensetzungen
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
DK0996430T3 (da) Nukleotidanalogsammensætninger
TR199800375A3 (tr) Selant kompozisyonlari.
ATE490311T1 (de) Mutanten der alpha-amylase
ID23374A (id) Halogenopirimidin
BR9813569B1 (pt) processo, e, composiÇço de aditivo alimentÍcio.
IL125124A0 (en) Dimeric forms of the protein fapalpha and uses thereof
IT1318319B1 (it) Composizione di gomma, procedimento per produrre la stessa e manicottoutilizzante la composizione di gomma.
ZA981017B (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines.
TR199501650A2 (tr) Agiz bilesimleri.
DE69832880D1 (de) Frazzled nukleotidsequenzen, expressionsprodukte, zusammensetzungen und verwendungen
BR9916537B1 (pt) composição de fragráncia, e, produto.
BR0012043B1 (pt) composiÇço de tratamento de cabelo.
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
DE69811651D1 (de) Enthaarungszusammensetzungen, die bereitung und die verwendung derselben
DE69831737D1 (de) Neurotrypsin
TR199501649A2 (tr) Agiz bilesimleri.
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
IT242987Y1 (it) Guarnitura per mobili.
DE69828906D1 (de) Herstellung von 1,3 propandiolestern
ATE251619T1 (de) 1,4-dioxacycloalkan-2-one und 1,4-dioxacycloalken-2-one
ZA984696B (en) Vaccine compositions V.
DE69908923D1 (de) 1,3,4-thiadiazolylazofarbstoffe-enthaltende tintenzusammensetzungen